P., S., M., M., & C., C. (2014). Outcomes with single agent LIPO-DOX in platinum-resistant ovarian and fallopian tube cancers and primary peritoneal adenocarcinoma - Chiang Mai University Hospital experience. Asian Pacific Organization for Cancer Prevention.
Chicago Style CitationP., Suprasert, Manopunya M., and Cheewakriangkrai C. Outcomes With Single Agent LIPO-DOX in Platinum-resistant Ovarian and Fallopian Tube Cancers and Primary Peritoneal Adenocarcinoma - Chiang Mai University Hospital Experience. Asian Pacific Organization for Cancer Prevention, 2014.
MLA引文P., Suprasert, Manopunya M., and Cheewakriangkrai C. Outcomes With Single Agent LIPO-DOX in Platinum-resistant Ovarian and Fallopian Tube Cancers and Primary Peritoneal Adenocarcinoma - Chiang Mai University Hospital Experience. Asian Pacific Organization for Cancer Prevention, 2014.